SONOMA PHARMACEUTICALS, INC. Interest Expense, Lessee, Assets under Capital Lease
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Interest Expense, Lessee, Assets under Capital Lease of $27.00 thousand for the 12-month period ending 2019-03-31, per its 10-K filed 2019-07-01.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseLesseeAssetsUnderCapitalLease · last filed 2019-07-01
- SONOMA PHARMACEUTICALS, INC. interest expense, lessee, assets under capital lease for fiscal 2019 was $27.00K, a 25.00% decline from fiscal 2018.
- SONOMA PHARMACEUTICALS, INC. interest expense, lessee, assets under capital lease for fiscal 2018 was $36.00K.
| Period end | Interest Expense, Lessee, Assets under Capital Lease 12 month |
|---|---|
| 2019-03-31 | $27.00K 10-K · filed 2019-07-01 |
| 2018-03-31 | $36.00K 10-K · filed 2018-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |